These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 2962417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R.
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [Abstract] [Full Text] [Related]

  • 3. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 4. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jun; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jun; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 6. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
    Loke DF, Ng CS, Samsioe G, Holck S, Ratnam SS.
    Contraception; 1990 Nov 15; 42(5):535-54. PubMed ID: 2125546
    [Abstract] [Full Text] [Related]

  • 8. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug 15; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives.
    Kuhl H, März W, Jung-Hoffmann C, Heidt F, Gross W.
    Am J Obstet Gynecol; 1990 Jul 15; 163(1 Pt 2):363-9. PubMed ID: 2142576
    [Abstract] [Full Text] [Related]

  • 10. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 15; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 11. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O, Kuusi T, Tikkanen MJ, Viinikka L.
    J Clin Endocrinol Metab; 1987 Dec 15; 65(6):1238-42. PubMed ID: 2960690
    [Abstract] [Full Text] [Related]

  • 12. Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
    Steinmetz A, Bauer K, Jürgensen R, Kaffarnik H.
    Eur J Obstet Gynecol Reprod Biol; 1990 Nov 15; 37(2):155-62. PubMed ID: 2147014
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb 15; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 14. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan 15; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 15. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov 15; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 16. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M, Feldman EB, Gillespy M, Gudat J.
    Am J Obstet Gynecol; 1989 May 15; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [Abstract] [Full Text] [Related]

  • 17. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Janaud A, Rouffy J, Upmalis D, Dain MP.
    Acta Obstet Gynecol Scand Suppl; 1992 May 15; 156():33-8. PubMed ID: 1324555
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov 15; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 19. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun 15; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L, Pasinetti E.
    Acta Obstet Gynecol Scand; 1995 Jan 15; 74(1):56-60. PubMed ID: 7856434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.